In the past 15 years, major progresses have been made in the understanding of the genetic basis of regulation of gene expression. These new insights have revolutionized our approach to resolve the genetic variation underlying complex diseases. Gene transcript levels were the first expression phenotypes that were studied. They are heritable and therefore amenable to Nonetheless, these associations have shown small size effects on the phenotypic variance of these traits leaving a large amount of unexplained heritability. In addition, only few causative variants have been actually identified. So far, for Mendelian diseases, causative variants have been found to be mostly coding with deleterious impact on proteins, 3, 4 whereas in complex traits, the associated variants predominantly fall in intronic or intergenic regions. 1, 2, 5, 6 Unfortunately, the identification of the causative variants is the final step often missing as it is highly challenging due to polygenicity, linkage disequilibrium (LD), cost, time and availability of relevant tissues.
Fortunately, while GWAS expanded, progresses in omics technologies have allowed the study of the human genome at the level of both its sequence, revealing the genetic diversity across populations, and of its expression at the various functional levels including the transcriptome, the proteome or the regulome. Characterizing these molecular traits has been essential. Studying them in light of genetic diversity has been a further step. Indeed, applying genetic approaches to these traits has opened a new era of "genetical genomics," a concept first coined in 2001. 7 In this endeavor, blood has been most extensively studied for obvious reasons (ease of collection and culture, wealth of markers), resulting in a bias of current data towards the hematopoietic and immune system. However, recent collaborative projects have started to investigate large panels of tissues and are closing the gap. This review outlines recent developments in the field along with its history, the methods behind it, and how it is applied to human genetics with emphasis on complex pathologies.
| LINKAGE DISEQUILIBRIUM, THE CORRELATION OF ALLELES IN A POPULATION, IS THE BASIS FOR GENETIC ASSOCIATION STUDIES
Genetic association is a powerful method to relate a genotype to a phenotype, the primary task of a geneticist. Its principle consists in correlating alleles or genotypes with a phenotype such as a disease or a quantitative trait (QT), for example, height or cholesterol level, in a population. It is based on linkage disequilibrium (LD), a fundamental relationship between alleles at pairs of genetically linked loci (Table 1) . Association studies use available genetic variants as markers and rely on the hypothesis that at least one of them is in LD with the unknown causative allele. Unfortunately, an allele reported as associated with a trait is very rarely causal. Most likely, it is in LD with the causative allele and, therefore, the association is indirect.
Another possibility not to forget is the existence of a false positive result.
On the basis outlined above, the principle of association tests is simply to assess the impact of marker alleles or genotypes on the phenotype. For diseases and binary traits, allele frequencies are compared between cases carrying the trait and matched controls using proportion comparison tests or logistic regression. For a continuous QT, a linear regression of the QT on the genotype is performed to identify the locus controlling it, termed QTL (quantitative trait locus) ( Figure 1) . Overall, association studies are powered to detect frequent variants having a small effect size on the trait by using large samples.
Once replicated, the next step is to fine-map association signals to identify causative variants. While a strong LD facilitates the discovery of an association, it becomes a major obstacle to identify the causative variant that cannot be statistically distinguished from the tested variants, especially when LD extends over several genes. Functional approaches are then necessary ( Figure 2 ).
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3 | GENOME-WIDE GENETIC STUDIES OF EXPRESSION PHENOTYPES
| eQTL (expression QTL): the first genomic endophenotypes
In multifactorial diseases, it is expected that most causative variants are regulatory, mainly acting through subtle modifications in the expression of messenger RNAs. 2 Two early examples were provided by the identification of the causative alleles at the INS and CHRNA1
loci, encoding the autoantigens in type 1 diabetes and autoimmune myasthenia gravis, respectively. They were shown to finely modulate the mRNA levels of these genes in the thymus, thereby affecting the central tolerance. 10, 11 The levels of gene expression can therefore be 
Definition
If we consider 2 genetically linked variants, each having 2 alleles, we expect to observe 4 pairwise combinations of these alleles, or haplotypes. If the alleles were independent or at linkage equilibrium, their frequencies should be the product of each allele frequency in the population. Likewise, for n biallelic variants, we expect to see 2 n haplotypes in the population. In fact, this random association of alleles is rarely observed, especially if the variants are physically close. We rather observe preferential allelic associations (ie, haplotype frequencies deviate from those expected at linkage equilibrium). The difference D between the observed and expected frequencies of a haplotype defines the LD of the 2 alleles on this haplotype. If 2 alleles are found together more often than expected, they are positively associated and their LD is positive. Conversely, the alternative combinations of alleles are less frequent than expected with the same absolute LD value but negative. There are different measures of LD. The most intuitive one for biallelic variants is their correlation estimated by their coefficient of determination r² ranging between 0 and 1. The LD is "complete" when at least 1 haplotype is missing and the most extreme case of LD said "perfect" is when only 2 of the 4 haplotypes are observed, with an r² of 1. In the latter case, both variants are redundant such that the genotype at the second variant can be imputed from the genotype at the first variant for any individual in the population. This has major consequences for genetic association studies (see main text).
Forces shaping the LD are intimately connected to the history of the population: LD depends on when the variants appeared in the population and how they evolved across the subsequent generations (see below):
Mutations/variations
Initially, when mutation creates a new allele at a locus near an established variant, there are only 3 haplotypes and therefore the LD is complete.
Meiotic recombination
Following mutation, the major force shaping the LD is meiotic recombination that creates the fourth haplotypes and therefore dissipates the LD. The higher the number of generations since the mutation has appeared and the higher the recombination rate between 2 loci, the lower the LD between their alleles. Thus distant loci are generally in lower LD. However, the recombination activity is not homogeneous along the genome: at a small scale, hot-spots of recombination shape islands of LD or haplotype blocks where a smaller number of haplotypes than expected are observed in the population. Their average size is~20 kb and varies between populations. However, it is important to remind that 2 variants in the same haplotype block are not always in LD and that, conversely, 2 variants may be in LD without being in the same haplotype block.
Demographic and evolutionary forces
By influencing variant allele frequencies, these forces also strongly impact the LD. For example, in a growing population, the LD decreases by increasing the number of recombinations. On the contrary, the genetic drift can fix some alleles, and thus the corresponding haplotypes, leading to new LD patterns. Migrations and population admixture also modify allele frequencies and LD. In population genetics, the time of a migration can be deduced from the LD decay. Recent positive selection can be detected with a higher LD around the selected variants. Epistatic interactions may also be selected and keep alleles in LD even if they are distant. This explains why LD depends on the considered haplotypes with different patterns for multi-allelic variants. For example, in the highly polymorphic human Major Histocompatibility Complex (MHC), LD may extend over long distances for some specific ancestral haplotypes. Finally, as allele frequencies vary substantially worldwide, both the extent and strength of LD also differ among populations.
regarded as intermediate phenotypes contributing to the disease outcome.
A major achievement was the demonstration that the variability of gene expression is heritable in humans. 12 These expression phenotypes are thus QTs amenable to genetic linkage and association analyses 13, 14 leading to coin the term of expression QTL (eQTL) 14 ( [35] [36] [37] [38] [39] [40] [41] [42] [43] ( 86 Subsequently, similar studies conducted on numerous primary tissues including adipose tissue, liver or human cortex, largely confirmed LCL findings and revealed that 30%-80% of eQTLs were cell-or tissue-specific notably in the brain. 35, [45] [46] [47] [48] A recent study even investigated induced pluripotent stem (iPS) cells.
Comparisons with 44 human tissues revealed that 32% of the eQTLs were specific to iPS cells. 87 It is thus necessary to directly investigate gene expression in the tissue of interest, which raises complex issues for the central nervous system. Moreover, tissues are often heterogeneous and, without enrichment, eQTLs specific for rare cell types can be masked. A seminal demonstration of cell specificity was made in a study conducted in monocytes and B cells of 288 healthy volunteers 88 showing that the majority of eQTLs were cell-specific and that 6% of the eSNPs regulated the expression of a different gene in each cell type. Conversely, different eSNPs could affect the expression of the same gene in each cell type. Opposing effects of the same eSNP could also be observed, for example, rs2223286*C allele decreased expression of SELL in monocytes but increased it in B cells.
An important kind of eQTLs, called response eQTLs (reQTLs), occurs following exposure to an external signal (Table 2 ), in particular in the immune system in response to infectious agents and to various stimuli. 49, 54, 55 Other environmental factors, including hormones, drugs, diet, metals or pollutants, can also be the source of reQTLs.
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Sex and age effects have also been identified. 57 One can anticipate that development-stage-specific eQTLs also exist in humans, as it has been reported in Drosophila.
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Altogether, these studies revealed important recurrent features of the thousands of eQTLs found in different tissues. Thus, almost 60%-80% of genes have at least one eQTL, 64 mostly cis-acting usually within 1 Mb of the transcription start site (TSS). 89 Distant eQTLs or even eQTLs lying on a different chromosome are less frequent, although a bias due to a lack of statistical power to detect them cannot be excluded. 90 A general rule is that the more distant the eQTLs, the more cell-and context-specific and the lower their effect sizes.
These distant eQTLs may be cis-eQTLs of a transcription factor (TF) that in turn controls distant targets. 91 Besides, a given transeQTL may control several genes and thus operate as a master regulator like in the Major Histocompatibility Complex (MHC). So far, eQTL variants were essentially eSNPs genotyped with microarrays while the contribution of copy number variants was evaluated at 17.7%. 92 The advent of next-generation sequencing might change the rules. The first study using a low-coverage whole-exome sequencing (WES) and RNASeq on the same 462 samples from the 1000 genomes project showed a significant enrichment for insertion/ deletions (indels) among the top eQTLs. 36 More recently, using WES with higher coverage and RNASeq data from 13 tissues of the GTEx Consortium (Table 3 ), up to 6.8% of cis-eQTLs were found to be driven by structural variants, including large deletions, duplications, inversions, mobile-element insertions and copy-number variants, with effects several-fold larger than those of SNPs and short indels. 93 Most notably, rare structural variants contributed a large fraction of gene expression variation.
In the above studies, the considered parameter of the gene expression distribution was the mean. However, the variance of QTs may also depend on the genotype, as shown with an FTO polymorphism on body mass index (BMI). 85 When impacting on the variance of gene expression, these variance QTLs (vQTLs) are called evQTLs or veQTLs. The few studies conducted so far in LCLs, skin and fat cells, have revealed a non-negligible number of veQTLs, with a large proportion being trans-acting 51,52 and a parent-of-origin effect for 12.6% of genes. 53 
| Extension to other "omics" expression phenotypes
Gene expression is complex and diverse. Most of the above studies considered protein-coding genes. However, the idea of expression phenotypes can be extended to non-coding genes, to posttranscriptional RNA modifications and to the post-translational level, introducing the general concept of molecular QTLs (molQTLs, Table 2 ).
According to the last release of GENCODE (version 27, https:// www.gencodegenes.org/releases/current.html), 94 there are currently twice as many non-coding RNAs genes as there are protein-coding genes, with a plethora of sizes, abundances and functions, amenable The two main challenges in fine-mapping GWAS hits: identifying the modulated genes and the causative variant. The minor allele rs1800629*A, alias TNF-308*A (red triangle), in the TNF gene promoter had been associated with numerous autoimmune and infectious diseases but consensus lacked on its regulatory role. Using the variant rs909253 (LTA+252, black) in LD with it, allele-specific expression assay revealed that the risk haplotype (alleles in brown) rather affects the expression of the neighbor LTA gene. 8 Fine-mapping shortlisted 3 other variants in LD. Using functional assays, the causative variant rs2239074 was identified in 5 0 UTR of LTA+80 (green), with its A allele binding the ABF1 transcriptional repressor. 9 For each SNP, the major allele is named first
The lincRNA eQTLs were mostly tissue-specific as the lincRNAs themselves. A more powered study highlighted some properties of lincRNAs eQTLs compared to those of protein-coding genes: ciseQTLs are more prevalent, 2.5-4.5 times closer to the TSS and have larger effect sizes, suggesting a relaxed purifying selection. 69 They directly regulate miRNA levels and are mostly located outside of the genomic region defined by the mature miRNA. Remarkably, 20%-33% of these were also associated to a variation of expression of their targets in immune cells. 36, 66, 67 Whether miR-eQTLs also affect protein levels remains to be explored.
Alternative splicing is a major mechanism driving transcriptome diversity, affecting 50%-74% of pre-mRNAs 96 and having a heritable pattern. 97, 98 It is more prevalent in the MHC than in other genomic regions, thus adding to the huge polymorphism of this region. 99 The genetic variants modulating exon usage have first been mapped as spliceQTLs (sQTL or asQTL) in different tissues. 15, 60, 61 With more accurate isoform quantification using RNASeq, it has become possible to map eQTLs for transcript ratios (trQTLs) 36, 64 and even for "composite" transcript ratios reflecting the equilibrium of all isoforms. 62, 63 Overall, the sQTLs are 4 to 6 times less frequent than eQTLs and act independently of them, although they are uncommon in the absence of global gene-level variation. sQTLs usually are intronic, falling at binding sites for the splicing machinery. They are also enriched in alternative exons. Alternative poly-adenylation (poly(A)) is another mechanism of transcript diversification generating 5% of isoforms. By modifying the 3 0 end of mRNAs, it alters their sensitivity to miRNAs and modulates their stability. About 2300 genes have a SNP that influences their poly(A) usage (poly(A) ratio QTLs) in whole-blood. 42 Finally, the aforementioned studies considered the steady-state transcript levels, without distinguishing mRNA production and decay rates. It is estimated that 19% of eQTLs could result from RNA decay.
Thus, 195 loci affecting the mRNA decay rates (rdQTLs) have been found in 70 LCLs. 70 Expression of proteins, the ultimate gene products in many cases, is also genetically regulated as showed by a study of 42 serum proteins in 1200 individuals that detected 8 cis protein QTLs (pQTLs) with large effect sizes. 73 Subsequently, the proteome of 95 HapMap
LCLs was characterized by mass spectrometry. 74 The most variable proteins were immune-related. This study confirmed a marked interindividual variability with 5.7% of proteins having at least a 1.5-fold variation in half of the sample pairs. However, only 77 cis-pQTLs were identified. Altogether, these pQTLs mapped preferentially in the 
| GENOME-WIDE GENETIC STUDIES OF EPIGENOMIC PHENOTYPES
Gene expression is primarily governed by chromatin structure, which determines DNA accessibility to regulatory transcriptional complexes.
Major epigenomic marks include DNA methylation, histone modifications, chromatin accessibility or nucleosome occupancy and chromosomal conformation. 102 Binding of TFs to DNA also belongs to the epigenetic framework. 28 Altogether, they define the epigenome. The
Encyclopedia of DNA Elements (ENCODE) has been the first major project to characterize it in-depth in a large panel of cell lines, providing the first genome-wide catalogue of functional regulatory elements. 103 Subsequently, international projects aiming at profiling epigenetic patterns in primary cells and tissues have relied on large consortia such as the NIH Roadmap Epigenomics Program, the International Human Epigenome Consortium or the BLUEPRINT project. 104 Epigenomic marks can be themselves considered as QTs. In this review, we call the associated variants epigenomic QTLs (epiQTL, Table 2 ). Because DNA is usually available and its methylation can be easily quantified, 5-methylcytosine methylation at CpG islands has been the most studied epiQTL. The corresponding methylation QTLs (meQTLs) 16 remain consistent across the lifespan in blood. 17 They mostly act in cis within 10 kb of the relevant CpG. Remarkably, about 10% of cis-meQTLs are also cis-eQTLs, thereby called expression quantitative trait methylation (eQTM), 30% of them surprisingly being correlated with an increased gene expression. They are also enriched for CCCTC-binding factor (CTCF)-and TF-binding sites as shown in brain, purified neurons, glia, T cells and placenta. 18 trans-meQTLs are less frequent (3%-7%) but may target hundreds of CpGs and several of them appear to be eQTLs in cis for CTCF or TFs. 19 Similarly, chromatin accessibility can be studied by mapping DNAse I hypersensitivity sites. The corresponding dsQTL are often (39%) associated with gene expression variation in LCLs. 23 Conversely, 55% of eQTLs are also dsQTLs. These functional dsQTLs are enriched in allele-specific TF-binding sites. Further studies performed jointly on several chromatin marks in LCLs identified extensive allele-dependent variation defining histone QTLs (hQTL). 20, [24] [25] [26] Histone marks at enhancers were the most variable ones. Enrichment of hQTLs in dsQTLs, eQTLs and meQTLs was observed. Of note, epiQTLs also correlated with sQTLs, albeit to a lesser extent than with eQTLs. 15 These studies pointed to the disruption of TF-binding sites as the key mechanism driving these coordinated changes of epigenomic marks. Overall, 15%
of the hQTLs can act both locally and distally. They define regions with coordinated chromatin state changes that are embedded within topologically associated domains (TADs). 27, 29 In this context, TFbinding QTLs (bQTL) were shown to also influence long-range chromosomal contacts. 31 These findings could be extended to primary blood cell subsets and highlighted the cell specificity of this chromatin coordination. 21 Altogether, current studies of eQTLs and other molQTLs, mostly bearing on immune cells, cast unprecedented light on the regulatory elements underlying gene expression, their spatial distribution across the genome and how they are correlated in the regulatory cascades, with half of the transcription variation explained by chromatin marks jointly with genetic variation.
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5 | TOWARDS THE IDENTIFICATION OF DISEASE-CAUSING VARIANTS
| Clear advantages of using molQTLs
In an effort to pinpoint the causative variants among the GWAS variants, the overlap with ENCODE elements provided interesting hints.
Thus, 13.1% of GWAS hits were found to map directly to an ENCODE element, while 59% were in LD with a SNP mapping to an ENCODE element. 103, 105 Similarly, in primary cells of the Epigenome Roadmap, 60% of GWAS variants for immune-mediated diseases mapped to "immune" enhancers and 10%-20% to TF-binding motifs. 6 However, connecting the associated alleles to phenotypes has been less straightforward because ENCODE and Epigenome Roadmap samples have a limited genetic diversity.
Catalogues of molQTLs thus provide invaluable tools to bridge the gap between genotypes and clinical phenotypes. 14, 43 The rationale is to prioritize the most credible candidate variants by intersecting the list of GWAS SNPs with that of molQTLs ( Figure 4A ), using for example, webportals like RegulomeDB 106 or HaploReg. 107 Following a first success in asthma, 108 this approach has become "classical."
Importantly, mapping eQTLs in healthy individuals is assumed to be equally informative, the only difference being the frequency of disease-risk alleles. Besides, tissues not available from patients can be studied, even post-mortem for the brain and other vital organs. 43 Finally, variation of gene expression is not biased by confounding factors due to the disease or its treatment. On this basis, wealth of studies have highlighted eQTLs at GWAS hits. 90, 109 Overall, there is a significant enrichment for all types of molQTLs in GWAS hits and reciprocally. 110 A classic example is the dissection of the 1p13 locus A "reverse" approach ( Figure 4B ) starts from the molecular trait showing difference between patients and controls, then identifies genetic variants controlling this difference and checks that the molQTLs are indeed associated with the clinical trait. Thus, the HDLcholesterol plasma level could be correlated with 67 transcripts regulated by a cis-eSNP. VNN1 was the best correlated transcript and showed 4 eSNPs in its promoter that were also associated with HDLcholesterol concentrations. 44 In systemic lupus erythematosus (SLE), both classical and reverse approaches were used. According to the classical one, the causative variant on chromosome 7 was found to act in cis on IKZF1. According to the reverse approach, this eQTL also explained in trans the previously known differential expression in SLE of the complement C1QB gene and 5 type I interferon response genes. 116 In this case, no new genetic variant was associated with the disease, but we propose that this reverse approach starting from gene expression may be used to rescue variants missed by GWAS.
Epigenomic traits, including DNA methylation and histone acetylation, have been also searched for differential effects by EpigenomeWide Association Studies (EWAS) or by Histone Acetylome-Wide Association Study (HAWAS). 30, 117 In complement of these studies, mapping of epiQTLs can help to discriminate the differential epigenomic marks due to the influence of the environment from those having a genetic basis, provided analyses are conducted in the same cell-context with careful experimental design. 28, 118 A third usage of molQTL in clinical genetics can be envisioned in the context of Mendelian traits ( Figure 4C ). Non-coding variants affecting gene expression can act as modifiers of the main diseasecausing locus by affecting its penetrance or expressivity. [119] [120] [121] MolQTLs in relevant tissues are a mine to search for these modifiers.
| Caution and limitations in using molQTLs
The fact that the molQTLs and the GWAS hits colocalize or are in strong LD does not imply that the disease association and the molec- revealed that only 25% of the lead GWAS SNPs were eQTLs, 75% of them being cell-specific. 132 A similar proportion was obtained in inflammatory bowel disease (IBD) after fine-mapping the disease variants with high confidence. 133 These surprising results, which remain to be confirmed in other diseases, are at odds with the previously established idea that the majority of GWAS hits are molQTLs. That being said, even before these two studies, it was not possible to assign a molQTL to every GWAS hit. One possibility is that a fraction of the non-coding GWAS hits is actually not explained by a molQTL. Alternatively, the molQTLs explaining the GWAS hits have not been found yet. There are several reasons for that which are discussed below.
Strikingly, most of these studies have a blind spot, the MHC, despite the fact that this region is the most prominent one in terms of GWAS associations. 134 Indeed, the MHC holds a special status. 135 It is characterized by a strong LD over megabases that complicates its fine-scale analysis. In addition, its extreme polymorphism impairs the interpretation of molQTLs for molecular traits assessed by solely using the reference sequence, arguing for dedicated approaches. 99 A second set of explanations pertains to the current incompleteness of molQTLs databases. Indeed, molQTLs studies are often underpowered, especially for molQTLs other than eQTLs and for trans-molQTLs whose effects are more often tissue-specific. In addition, quantification methodologies for a given molecular trait are heterogeneous and genome-wide significance thresholds vary between molQTL studies. This may explain, for instance, the limited overlap between 4 eQTL resources for blood pressure associations. 136 A final point is the frequent lack of the appropriate biological context in the molQTL databases. We have previously emphasized the importance of the tissue or cell type for molQTLs. The importance of the relevant context in fine-mapping of disease-causing variants has been underscored by the robust colocalization of hits from 57 GWAS with eQTLs from 24 different cells and tissues. 137 Likewise, GWAS hits are more enriched for reQTLs than for constitutive QTLs. 59 Ultimately, a first eQTL mapping recently performed on single cells from whole blood has strengthened this argument of cell specificity by identifying a significant proportion of cell-specific eQTLs undetected in bulk RNA. 138 Along this line, a method has been proposed to infer cell types to relevant complex diseases using single-cell eQTLs. 139 The complex inheritance of molQTLs resulting from allelic heterogeneity, On the left, the molQTL is in cis with the disease-causing mutation and upregulates the mutant transcript, potentially exacerbating the disease. Note that if the mutation results in reduced function, it may instead rescue the phenotype. On the right, the molQTL upregulates the wild-type transcript, potentially attenuating the disease severity impacts on their interpretation and the causality inference to complex diseases. It is sometimes difficult to tease apart these effects. For instance, epistasis between two eSNPs without pairwise LD could be explained by a third eSNP in low LD with them. 144 Related to epistasis is the notion of context-dependency whereby an eQTL is influenced by the expression of another gene detected by interaction modeling. For example, expression of NOD2 in whole blood is explained by an eQTL whose effect is substantially increased when STX3A, a neutrophils marker, is highly expressed. 42 Locus pleiotropy is illustrated by the SLC16A11 haplotype, a major risk for T2D in
Mexico that contains regulatory variants decreasing its transcript level in liver. But, in addition, coding variants act at the posttranslational level by impairing binding to its chaperone, resulting in a decreased surface expression. 145 And similarly to complex traits, there is missing heritability with, for instance, current estimates of 69% for expression phenotypes in whole blood. 146 A final difficulty stems from the interplay between the different molQTLs. There is no one-to-one relationship in their "percolation"
cascade. This lack of linearity is exemplified by the non-independence of molecular traits. In fact, molecular traits show covariance both within and between each omic layer. To tackle this, trans-molQTLs are a first step forward to infer module networks. New methods are developed to integrate multiple molecular phenotypes. 29, 72, 91, 147 Human quantitative genetics is thus leaping into the area of systems biology. 2 This complexity emphasizes the absolute necessity to conduct functional studies to validate genetic findings. In this endeavor, the emergence of high-throughput genomics methods to edit the genome and to investigate the phenotypic impact of candidate variants will be essential to dissect the huge number of GWAS hits. 149, 150 
